Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

Professor Wolfgang Koenig MD, PhD, FRCP, FACC, FAHA, FESC

Professor of Medicine/Cardiology at the University of Ulm Medical School, Ulm, Germany

German Heart Center Munich, Technical University of Munich, Munich, Germany

Wolfgang Koenig is a Professor of Medicine/Cardiology at the University of Ulm Medical School, Ulm, Germany. He is a Board certified Internist and interventional cardiologist, and also specialized in Intensive Care Medicine. In addition he has extensive experience in the molecular epidemiology of cardiovascular diseases. After different prestigious positions as a former Director of the WHO-MONICA Augsburg Myocardial Infarction Register, Deputy Director of the Departments of Medicine and Head of the Emergency Room, Director of the Intensive Care Unit, and Director of Cardiovascular Laboratories, he has been the Director of the Preventive Cardiology Program and the Clinical Trial Unit (CTU) at the Department of Internal Medicine II - Cardiology of the University of Ulm Medical Center until March 2015. In April 2015 he joined the Deutsches Herzzentrum München, Technische Universität München and became an established investigator of the Munich Heart Alliance within the DZHK (German Centre for Cardiovascular Research) and is Head of the Cardiometabolic Unit. Presently he serves also on the Steering Committee of various large international randomized clinical trials testing innovative targets in cardiovascular medicine.

Dr. Koenig`s research interests involve the molecular basis of atherothrombogenesis including genetics with particular interest in the interrelations between hemostasis, inflammation, and atherothrombotic complications / type 2 diabetes, the metabolic syndrome, the clinical pharmacology of cardiovascular active compounds, and the clinical epidemiology of cardiovascular disorders, focusing on the identification and evaluation of novel biomarkers for cardiometabolic diseases.

He has received funding from the German Research Foundation (DFG), the German Ministry of Research and Technology (BMBF; NGFN-2 and NGFNplus), the European Union (AIRGENE, AtheroRemo, BiomarCaRE), the European Research Agency (ERA-CVD) and several foundations. He also serves as a regular reviewer for various prestigious international journals, research foundations and institutions.

Dr. Koenig has an impressive publication list of more than 800 papers, many of them in first rank journals. He ranks number 6 of the most frequently cited German speaking researcher in cardiovascular disease between 2008 and 2012 and has an H-index of 93. He is a member of the Editorial Board of “Clinical Chemistry” and Associate Editor of “Cardiovascular Drugs and Therapy”. In 2014 he was given the Rudolf Schönheimer Award from the German Atherosclerosis Society. In 2019 he received the degree of Adjunct Professor from the Medical University of Vienna.

« Back to Editorial Board